Loading clinical trials...

Evaluation of Corneal Epithelial Thickness Mapping | Clinical Trials | Clareo Health

COMPLETEDNCT01712022

Evaluation of Corneal Epithelial Thickness Mapping

Optovue has developed a new feature for mapping corneal epithelial thickness. The purpose of the study is to evaluate the accuracy and repeatability of the epithelial thickness measurement. Consented ...

Lead sponsor: Optovue•3 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment88

Start dateOct 2012

Last updatedSep 11, 2014

Condition

Dry Eye and Contact Lens Wear

Locations shown

Fishman Vision

Palo Alto, California

Gordon-Weiss-Schanzlin Vision Institute

San Diego, California

Brass Eye Center

Latham, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 11, 2014Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions